178 related articles for article (PubMed ID: 30709778)
1.
Kane JPM; Roberts G; Petrides GS; Lloyd JJ; O'Brien JT; Thomas AJ
Parkinsonism Relat Disord; 2019 May; 62():79-84. PubMed ID: 30709778
[TBL] [Abstract][Full Text] [Related]
2. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
[TBL] [Abstract][Full Text] [Related]
3. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
[TBL] [Abstract][Full Text] [Related]
4. Potential diagnostic value of
Abbasi M; Ghalandari N; Farzanefar S; Aghamollaii V; Ahmadi M; Ganji M; Afarideh M; Loloee S; Naseri M; Tafakhori A
Clin Neurol Neurosurg; 2017 Dec; 163():163-166. PubMed ID: 29112909
[TBL] [Abstract][Full Text] [Related]
5. Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
Camacho V; Marquié M; Lleó A; Alvés L; Artigas C; Flotats A; Duch J; Blesa R; Gómez-Isla T; Carrió I; Estorch M
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):476-83. PubMed ID: 21150861
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.
Yoshita M; Arai H; Arai H; Arai T; Asada T; Fujishiro H; Hanyu H; Iizuka O; Iseki E; Kashihara K; Kosaka K; Maruno H; Mizukami K; Mizuno Y; Mori E; Nakajima K; Nakamura H; Nakano S; Nakashima K; Nishio Y; Orimo S; Samuraki M; Takahashi A; Taki J; Tokuda T; Urakami K; Utsumi K; Wada K; Washimi Y; Yamasaki J; Yamashina S; Yamada M
PLoS One; 2015; 10(3):e0120540. PubMed ID: 25793585
[TBL] [Abstract][Full Text] [Related]
7. [(123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia].
Marquié Sayagués M; Da Silva Alves L; Molina-Porcel L; Alcolea Rodríguez D; Sala Matavera I; Sánchez-Saudinós MB; Camacho Martí V; Estorch Cabrera M; Blesa González R; Blesa González R; Gómez-Isla T; Gómez-Isla T; Lleó Bisa A; Lleó Bisa A
Neurologia; 2010 Sep; 25(7):414-21. PubMed ID: 20964987
[TBL] [Abstract][Full Text] [Related]
8. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
Colloby SJ; Firbank MJ; Pakrasi S; Lloyd JJ; Driver I; McKeith IG; Williams ED; O'Brien JT
Int Psychogeriatr; 2008 Dec; 20(6):1124-40. PubMed ID: 18752700
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis.
Slaets S; Van Acker F; Versijpt J; Hauth L; Goeman J; Martin JJ; De Deyn PP; Engelborghs S
Int J Geriatr Psychiatry; 2015 Aug; 30(8):864-9. PubMed ID: 25363642
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
Roberts G; Durcan R; Donaghy PC; Lawley S; Ciafone J; Hamilton CA; Colloby SJ; Firbank MJ; Allan L; Barnett N; Barker S; Howe K; Ali T; Petrides GS; Lloyd J; Taylor JP; O'Brien J; Thomas AJ
Neurology; 2021 Jun; 96(23):e2801-e2811. PubMed ID: 33883238
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
Shimizu S; Kanetaka H; Hirao K; Fukasawa R; Namioka N; Hatanaka H; Hirose D; Umahara T; Sakurai H; Hanyu H
Geriatr Gerontol Int; 2017 May; 17(5):819-824. PubMed ID: 27138074
[TBL] [Abstract][Full Text] [Related]
14. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.
Walker Z; Jaros E; Walker RW; Lee L; Costa DC; Livingston G; Ince PG; Perry R; McKeith I; Katona CL
J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1176-81. PubMed ID: 17353255
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.
Taylor JP; Colloby SJ; McKeith IG; Burn DJ; Williams D; Patterson J; O'Brien JT
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1069-71. PubMed ID: 17299017
[TBL] [Abstract][Full Text] [Related]
16. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
Hanyu H; Shimizu S; Hirao K; Kanetaka H; Iwamoto T; Chikamori T; Usui Y; Yamashina A; Koizumi K; Abe K
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506
[TBL] [Abstract][Full Text] [Related]
17. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.
Yoshita M; Taki J; Yamada M
J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):583-8. PubMed ID: 11606666
[TBL] [Abstract][Full Text] [Related]
18.
Komatsu J; Samuraki M; Nakajima K; Arai H; Arai H; Arai T; Asada T; Fujishiro H; Hanyu H; Iizuka O; Iseki E; Kashihara K; Kosaka K; Maruno H; Mizukami K; Mizuno Y; Mori E; Nakamura H; Nakano S; Nakashima K; Nishio Y; Orimo S; Takahashi A; Taki J; Tokuda T; Urakami K; Utsumi K; Wada K; Washimi Y; Yamashina S; Yamasaki J; Yoshita M; Yamada M
J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1167-1173. PubMed ID: 29853532
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
McCleery J; Morgan S; Bradley KM; Noel-Storr AH; Ansorge O; Hyde C
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010633. PubMed ID: 25632881
[TBL] [Abstract][Full Text] [Related]
20. [Dementia with Lewy bodies and Alzheimer's disease: differential diagnosis by cardiac sympathetic innervation MIBG imaging].
Estorch M; Camacho V; Fuertes J; Rodríguez-Revuelto A; Hernández MA; Flotats A; Kulisevsky J; Carrió I
Rev Esp Med Nucl; 2006; 25(4):229-35. PubMed ID: 16827985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
